Nonalcoholic fatty liver disease; metabolic syndrome; lipid metabolism; hepatic metabolic pathways; aerobic capacitynonalcoholic fatty liver disease; insulin resistance; gut microbiota; coronary artery disease; hepatic metabolic pathways. This evidence concerns the gene INS and fatty liver disease.